메뉴 건너뛰기
Oncologist
Volumn 9, Issue SUPPL. 4, 2004, Pages 1-2
Optimizing bisphosphonate therapy in oncology
Author keywords

[No Author keywords available]
Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ZOLEDRONIC ACID;
EID: 5444249828     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-90004-1     Document Type: Conference Paper
Times cited : (2)
References (4)
  • 1
    • 5444262558 scopus 로고    scopus 로고
    • Bisphosphonates: Clinical experience
    • Coleman RE. Bisphosphonates: clinical experience. The Oncologist 2004;9(suppl 4):14-27.
    • (2004) The Oncologist , vol.9 , Issue.4 SUPPL. , pp. 14-27
    • Coleman, R.E.1
  • 2
    • 5444243800 scopus 로고    scopus 로고
    • Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
    • Conte PF, Guarneri V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. The Oncologist 2004;9(suppl 4):28-37.
    • (2004) The Oncologist , vol.9 , Issue.4 SUPPL. , pp. 28-37
    • Conte, P.F.1    Guarneri, V.2
  • 3
    • 5444242637 scopus 로고    scopus 로고
    • Bisphosphonates: Preclinical review
    • Green JR. Bisphosphonates: preclinical review. The Oncologist 2004;9(suppl 4):3-13.
    • (2004) The Oncologist , vol.9 , Issue.4 SUPPL. , pp. 3-13
    • Green, J.R.1
  • 4
    • 5444253259 scopus 로고    scopus 로고
    • Toward new horizons: The future of bisphosphonate therapy
    • Lipton A. Toward new horizons: the future of bisphosphonate therapy. The Oncologist 2004;9(suppl 4):38-47.
    • (2004) The Oncologist , vol.9 , Issue.4 SUPPL. , pp. 38-47
    • Lipton, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.